Article Details

Samsung Bioepis (CEO Kim Kyung-ah) announced on the 8th that it has launched its rare ...

Retrieved on: 2025-04-08 01:44:30

Tags for this article:

Click the tags to see associated articles and topics

Samsung Bioepis (CEO Kim Kyung-ah) announced on the 8th that it has launched its rare .... View article details on hiswai:

Excerpt

Episcly is a biosimilar of Soliris, a rare disease treatment developed by Alexion in the United States, and is a treatment for rare diseases such ...

Article found on: www.mk.co.kr

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up